Maia Biotechnology Inc (MAIA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,313 | -6,370 | -22,396 | -18,767 | -9,864 |
| Accounts payable and accrued liabilities | 796 | 941 | 520 | 1,658 | 206 |
| Other Working Capital | 821 | 620 | 1,499 | 5,818 | 856 |
| Other Operating Activity | 635 | -502 | 1,533 | -532 | 465 |
| Operating Cash Flow | $-12,061 | $-5,311 | $-18,845 | $-11,824 | $-8,338 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 33,047 | 33,047 | 18,524 | 13,603 | 9,251 |
| Other Financing Activity | -2,060 | -1,995 | -617 | -498 | -381 |
| Financing Cash Flow | $30,987 | $31,052 | $17,907 | $13,104 | $8,869 |
| Exchange Rate Effect | 12 | 14 | -5 | 10 | 11 |
| Beginning Cash Position | 8,658 | 8,658 | 9,601 | 9,601 | 9,601 |
| End Cash Position | 27,596 | 34,413 | 8,658 | 10,892 | 10,145 |
| Net Cash Flow | $18,938 | $25,755 | $-943 | $1,290 | $543 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,061 | -5,311 | -18,845 | -11,824 | -8,338 |
| Free Cash Flow | -12,061 | -5,311 | -18,845 | -11,824 | -8,338 |